News Focus
News Focus
icon url

Biobillionair

01/09/19 6:56 AM

#171028 RE: Biobillionair #171027

Amarin also addresses clear revenue projections:

Projection assumes no benefit in 2019 from expanded label; after label expansion increased promotion to
consumers anticipated to further accelerate revenue growth in this multi-billion dollar opportunity



Label expansion and increase in sales is NOT projected.

BB
icon url

jessellivermore

01/09/19 8:08 AM

#171042 RE: Biobillionair #171027

BB...

Very important point..Primary intervention is actually a bigger market for Vascea than secondary and it means targeting T2DMs also...

":>) JL